Type 2 Diabetes

ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c ...

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend ...

Ask the Experts: Dr Goyal on SGLT2 Inhibitors

Dr Goyal from NYU Langone Health in New York City talks about SGLT2 inhibitors in the treatment of type 2 diabetes.

Addressing Psychological Insulin Resistance in Patients With Diabetes

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD ...

Video

Latest Headlines

Exposure to Maternal Diabetes Increases Risk for ADHD in Offspring

Exposure to Maternal Diabetes Increases Risk for ADHD in Offspring

The 3 main types of diabetes during pregnancy were associated with offspring ADHD risk in a hierarchical order.

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

High circulating total prolactin concentrations may be linked with a lower risk for type 2 diabetes in women.

Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes

Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes

Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.

Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection

Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection

The study compared US administrative claims data of HCV patients with ≥12 weeks of dispensed DAA therapy (N = 17,848) to untreated HCV patients with follow-up data (N = 108,350).

ADA Issues Position Statement on Comprehensive Care for Pediatric T2D

ADA Issues Position Statement on Comprehensive Care for Pediatric T2D

The American Diabetes Association issued a position statement outlining the recognition, management, and prevention of T2D in the pediatric population.

Peer Support Reduces Hospitalizations in People With Diabetes and Depression

Peer Support Reduces Hospitalizations in People With Diabetes and Depression

Patients with diabetes and depressive symptoms who received community-based peer support for diabetes management reported less frequent acute care visits and hospitalizations than patients with diabetes without depressive symptoms.

Pathogenesis of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass in T2D

Pathogenesis of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass in T2D

Postprandial hypoglycemia may occur after Roux-en-Y gastric bypass in patients with type 2 diabetes, independent from diabetes remission.

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization in T2D

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization in T2D

Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.

Acute and Persistent Prothrombic Effects Observed With Antecedent Hypoglycemia in T2D

Acute and Persistent Prothrombic Effects Observed With Antecedent Hypoglycemia in T2D

Hypoglycemia was associated with early and late prothrombotic changes in the fibrin network in individuals with type 2 diabetes.

Sign Up for Free e-Newsletters



CME Focus